Citation Impact
Citing Papers
New clinical trials for nonmotor manifestations of Parkinson's disease
2015
Comprehensive Examination of Therapies for Pain in Parkinson’s Disease: A Systematic Review and Meta-Analysis
2018
Parkinson disease
2017 Standout
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Pains in Parkinson disease—many syndromes under one umbrella
2012
Canadian guideline for Parkinson disease
2019 Standout
Parkinson's disease
2015 Standout
Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer
2018 Standout
Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate
2012
Beyond factor analysis: Multidimensionality and the Parkinson’s Disease Sleep Scale-Revised
2018
Non-motor features of Parkinson disease
2017 Standout
Therapies in Parkinsonʼs disease
2012
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
2011
Therapeutic options for nocturnal problems in Parkinson’s disease and atypical parkinsonian disorders
2014
The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study
2019
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Clinical Perspectives on Lacosamide
2008
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
2015
Nonmotor Symptoms in Nursing Home Residents with Parkinson's Disease: Prevalence and Effect on Quality of Life
2013
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of John Whitesides being referenced
Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study
2012
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)
2010
Intravenous lacosamide as short‐term replacement for oral lacosamide in partial‐onset seizures
2009
Intravenous lacosamide as replacement for oral lacosamide in patients with partial‐onset seizures
2007
A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease
2014